PURPLE BIOTECH LTD. (PPBT) Net income 2016–2025
PURPLE BIOTECH LTD. (PPBT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.4MFY2025 · since FY2016: $12.1M → -$26.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.4M | -264.4% |
| FY2024 | -$7.2M | +63.6% |
| FY2023 | -$19.9M | +8.3% |
| FY2022 | -$21.7M | -217.9% |
| FY2021 | $18.4M | -34.3% |
| FY2020 | $28.0M | +378.6% |
| FY2019 | $5.8M | +12.5% |
| FY2018 | $5.2M | -57.3% |
| FY2017 | $12.2M | +0.4% |
| FY2016 | $12.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating incomePPBT Operating marginPPBT Operating cash flowPPBT Free cash flowPPBT Capital expendituresPPBT Return on equityPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Total liabilitiesPPBT Shareholders’ equityPPBT overview →